semaglutide acute kidney injury Long-term outcomes of in obesity and cardiovascular disease in the SELECT trial Cardio-kidney-metabolic protective effects of semaglutide
Description
GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health
Despite the development of several drugs for neuropathic pain management, their poor efficacy, tolerance, addiction potential, and side ...
Its frustrating to watch, given my field of study.
The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients
A kutatk sem mindig tudjk, mitl mkdnek, de figyelmeztetnek: a GLP-1 analgoknak veszlyeik is lehetnek.
Epub 2024 Feb 5
